Developer docs
API playgroundTry for free, no card

Search company profiles

Equasens

Full company profile

uuid00098ie

Namestring
Equasens
Legal namestring
Equasens
Websiteurl
equasens.com
Company typeenum
Public
Founded yearint
1996
Descriptiontext

Equasens is a France-headquartered, Euronext Paris-listed (ticker: QUIS) digital healthcare IT group serving more than 25,000 healthcare establishments across Europe. The group operates through five core divisions: Pharmagest (pharmacy management software), Axigate Link (hospital and medico-social software, including the recently integrated ResUrgences and DIS activities serving 300+ public-health clients), Medical Solutions (electronic patient records and practice management for independent physicians, MSPs, and CPTS), e-Connect (connected electronic medical devices), and Fintech (equipment leasing and financing for healthcare professionals). Equasens positions its portfolio around the full city–hôpital–medico-social care continuum, with explicit support for French regulatory frameworks including the Ségur du numérique en santé.

The group's customer base is highly diversified and includes 10,300 pharmacies, 3,400 care homes (EHPAD), 11,300 doctors, 40 hospitals, 170 hospital-at-home units (HAD), and 340 in-home nursing services (SSIAD). Equasens extends into adjacent verticals through Atoopharm (pharmacist continuing education) and, following the January 2025 acquisition of an 80% stake in Erevo, continuing medical education for physicians and allied health professionals. Geographically, Equasens has expanded beyond France into Germany through its wholly-owned ADV (PHARMAGEST Germany) subsidiary, and reports a multi-language European footprint covering French, English, German, Dutch, and Italian markets.

Equasens generates revenue through a mix of recurring software subscriptions, hardware sales of connected medical devices, and fintech/managed services for equipment leasing. It reports revenue on a quarterly basis, with Q3 2025 revenue of €172.2M (+8.9% reported, +7.3% like-for-like) and full-year 2025 guidance of nearly 10% total revenue growth. The company is part of the LA COOPÉRATIVE WELCOOP cooperative group and employs over 1,500 people across Europe. Notable recent acquisitions include Calimed Health (December 2024) and Erevo (January 2025), funded in part through bank financing, signalling an active inorganic growth strategy alongside organic expansion.

Short descriptiontext

Equasens is a Euronext Paris-listed (ticker: QUIS) French digital healthcare IT group serving over 25,000 pharmacies, hospitals, care homes, physicians, and home-care providers across Europe through five divisions covering software, connected devices, and equipment financing.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersVillers-lès-nancy, France
HQ citystring
Villers-lès-nancy
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare IT software, pharmacy management software, electronic patient records, connected medical devices, medico-social software
Industry1 code
1Pharmacy Interoperability, Standards & Integration (FHIR/NCPDP)
CodeHLACAKAOPrimaryYes
NAICS code1 code
  • Health Care and Social Assistance62
SIC code1 code
  • Services-Health Services8000
Product category
Healthcare IT Software
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Software Subscriptions and Licenses
TypeSubscription Recurring
Description

Recurring software subscriptions for pharmacy management, hospital software, and medical practice solutions

equasens.com:443
2Hardware and Connected Devices
TypeHardware Sales
Description

Sale of electronic devices and connected solutions for healthcare professionals and patients through e-Connect division

equasens.com:443
3Fintech/Financing Services
TypeManaged Services
Description

Equipment leasing and financing solutions for healthcare professionals (Fintech division)

equasens.com:443
4Systems and Equipment
TypeHardware Sales
Description

Healthcare systems and equipment segment showing significant growth driven by healthcare investments and new product rollouts

globenewswire.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Equasens develops and sells software solutions and connected electronic devices for healthcare professionals across Europe. Its portfolio covers pharmacy management software, hospital and medico-social information systems, electronic patient records for physicians, connected medical devices, and equipment financing — organized across five divisions (Pharmagest, Axigate Link, Medical Solutions, e-Connect, Fintech) to support care coordination across the city-hospital-medico-social continuum.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Equasens is a healthcare IT solutions provider organized into 5 strategic divisions: Pharmagest (pharmacy software), Axigate Link (hospital and medical-social software), Medical Solutions (physician practice management), e-Connect (connected medical devices), and Fintech (equipment financing). The company serves pharmacies, hospitals, care homes, physicians, and other healthcare professionals across Europe. The portfolio includes acquired brands like ADV (PHARMAGEST Germany), Erevo (digital training), and ResUrgences/DIS (hospital software), with a total customer base of 10,300 pharmacies, 3,400 care homes, 170 hospital-at-home units, 340 in-home nursing services, 11,300 doctors, and 40 hospitals.

Product and service6 records
1Pharmagest
CategoryPharmacy Management Software
Description

European expert in technological solutions for pharmacies, providing software and connected solutions for pharmacy management, dispensing, inventory control, and patient management across Europe. Serves over 10,300 pharmacies.

2Axigate Link
CategoryHospital and Medico-Social Software
Description

European expert in software and applications for medico-social, health, and multidisciplinary establishments. Provides hospital information systems, patient records, inter-establishment coordination, and care pathway software for hospitals and medical-social institutions.

3Medical Solutions
CategoryElectronic Patient Records and Practice Management
Description

Expert in Electronic Patient Records (EPR) and management of practices and nursing homes. Provides software for independent physicians (liberal doctors), group practices, MSPs (Maisons de Santé Pluriprofessionnelles), and CPTS (Communautés Professionnelles Territoriales de Santé).

4e-Connect
CategoryConnected Medical Devices
Description

Designer and manufacturer of connected electronic devices and solutions for healthcare professionals and patients. Offers connected medical devices for pharmacy, hospital, and patient use as part of Equasens' integrated healthcare IT ecosystem.

5Fintech
CategoryEquipment Financing Services
Description

Provides funding solutions for leased equipment for healthcare professions and other players in the services industry. Offers financing services (equipment leasing) to healthcare professionals to support acquisition of IT and medical equipment.

6ADV (PHARMAGEST Germany)
CategoryPharmacy Management Software (Germany)
Description

Germany-based pharmacy software company offering pharmacy software solutions for the German market. Acquired by Equasens in November 2023 to expand pharmacy software offerings and strengthen Equasens' presence in Germany.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierStrategicTypeStrategic or Co-development PartnerAnnounced on2026-01-05
Description

Equasens acquired 80% controlling stake in French digital training company Erevo, expanding into continuing medical education market. Deal expected to generate approximately €7.4 million revenue for Erevo in 2025. Combines Erevo's training programs with Equasens' existing Atoopharm training unit for pharmacists.

2ADV (PHARMAGEST Germany)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-11-01
Description

Acquired Germany-based ADV (PHARMAGEST Germany) to expand pharmacy software offerings and strengthen presence in German market. Part of European expansion strategy.

openpr.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Training unit within Equasens providing continuing education for pharmacists. Combined with Erevo acquisition to create synergies in medical education market.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Co-organized webinar on HPV vaccination in pharmacies with Equasens and Atoopharm to highlight public health issues and levers available to pharmacists for increasing vaccination rates.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Oracle Health (formerly Cerner) is a global EHR and healthcare IT incumbent serving large hospitals and health systems. It is an indirect competitor to Equasens at the high end of the European hospital market and pressures pricing on integrated care record initiatives.

TypeDirect peer
Description

Maincare Solutions is a French hospital information system provider serving public hospitals and health territories. It is a direct peer to Equasens' Axigate Link division and competes for the same French public hospital and GHT (groupement hospitalier de territoire) contracts.

TypeBroad incumbent
Description

Epic Systems is a leading global EHR vendor increasingly penetrating European large hospital systems. While not a direct daily competitor to Equasens today, it sets the enterprise functionality benchmark that Equasens' Axigate Link hospital offering must differentiate against in public tenders.

TypeDirect peer
Description

Cegedim is a French health technology group providing pharmacy management, physician EHR, and healthcare data solutions across Europe. It directly competes with Equasens' Pharmagest and Medical Solutions divisions and serves a similar B2B healthcare professional customer base.

TypeEmerging player
Description

Doctolib is the dominant European digital health platform for appointment booking, teleconsultation, and physician practice software in France and Germany. It overlaps with Equasens' Medical Solutions physician EHR offerings as an emerging cloud-native competitor.

TypeDirect peer
Description

CompuGroup Medical is a leading European health IT vendor with strong pharmacy software, physician practice, and hospital information system offerings, particularly in Germany. It is the most direct comparable to Equasens' pharmacy franchise and ADV (PHARMAGEST Germany) operations.

TypeBroad incumbent
Description

Agfa HealthCare provides enterprise imaging, hospital IT, and digital radiology solutions to hospitals and health systems globally. It is a broader incumbent that competes with Equasens' Axigate Link hospital software offering, particularly in imaging-adjacent workflows.

TypeBroad incumbent
Description

Dedalus is one of Europe's largest healthcare IT vendors, focused on hospital and diagnostic information systems across multiple countries. It competes with Equasens' Axigate Link hospital and medico-social software at a broader, more enterprise-oriented scale.

TypeOthers
Description

InterSystems provides health data platforms (HealthShare, IRIS for Health) used by hospital systems and national health authorities for interoperability. It is an enabling technology peer to Equasens' Healthcare Data Sharing Platform, competing as infrastructure rather than as a direct end-user application vendor.

TypeDirect peer
Description

MIMS Group (formerly Vidal) provides drug information databases and clinical decision support to pharmacies and physicians across Europe and Asia. It overlaps with Equasens' pharmacy and physician software offerings where drug database integration and medication safety features are core functions.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Equasens

Healthcare IT Softwareequasens.com

Equasens is a Euronext Paris-listed (ticker: QUIS) French digital healthcare IT group serving over 25,000 pharmacies, hospitals, care homes, physicians, and home-care providers across Europe through five divisions covering software, connected devices, and equipment financing.

What Equasens does

Equasens is a France-headquartered, Euronext Paris-listed (ticker: QUIS) digital healthcare IT group serving more than 25,000 healthcare establishments across Europe. The group operates through five core divisions: Pharmagest (pharmacy management software), Axigate Link (hospital and medico-social software, including the recently integrated ResUrgences and DIS activities serving 300+ public-health clients), Medical Solutions (electronic patient records and practice management for independent physicians, MSPs, and CPTS), e-Connect (connected electronic medical devices), and Fintech (equipment leasing and financing for healthcare professionals). Equasens positions its portfolio around the full city–hôpital–medico-social care continuum, with explicit support for French regulatory frameworks including the Ségur du numérique en santé.

The group's customer base is highly diversified and includes 10,300 pharmacies, 3,400 care homes (EHPAD), 11,300 doctors, 40 hospitals, 170 hospital-at-home units (HAD), and 340 in-home nursing services (SSIAD). Equasens extends into adjacent verticals through Atoopharm (pharmacist continuing education) and, following the January 2025 acquisition of an 80% stake in Erevo, continuing medical education for physicians and allied health professionals. Geographically, Equasens has expanded beyond France into Germany through its wholly-owned ADV (PHARMAGEST Germany) subsidiary, and reports a multi-language European footprint covering French, English, German, Dutch, and Italian markets.

Equasens generates revenue through a mix of recurring software subscriptions, hardware sales of connected medical devices, and fintech/managed services for equipment leasing. It reports revenue on a quarterly basis, with Q3 2025 revenue of €172.2M (+8.9% reported, +7.3% like-for-like) and full-year 2025 guidance of nearly 10% total revenue growth. The company is part of the LA COOPÉRATIVE WELCOOP cooperative group and employs over 1,500 people across Europe. Notable recent acquisitions include Calimed Health (December 2024) and Erevo (January 2025), funded in part through bank financing, signalling an active inorganic growth strategy alongside organic expansion.

Equasens firmographics

Firmographics
Name
Equasens
Legal name
Equasens
Website
https://equasens.com
Company type
Public
Founded year
1996
Operating status
Operating
Headcount range
251–500 employees
Short description
Equasens is a Euronext Paris-listed (ticker: QUIS) French digital healthcare IT group serving over 25,000 pharmacies, hospitals, care homes, physicians, and home-care providers across Europe through five divisions covering software, connected devices, and equipment financing.
Ownership category
akta.pro rank

Equasens industry classification

Industry
Product category
Healthcare IT Software
NAICS
Health Care and Social Assistance (62)
SIC
Services-Health Services (8000)
akta.pro primary industry
Pharmacy Interoperability, Standards & Integration (FHIR/NCPDP) (HLACAKAO)

Keywords

  • Healthcare IT software
  • Pharmacy management software
  • Electronic patient records
  • Connected medical devices
  • Medico-social software

Where Equasens is headquartered

Location

Headquarters

HQ city
Villers-lès-nancy
HQ country
France
HQ region
Europe

Offices2 records

Markets served

Equasens business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

  1. Software Subscriptions and Licenses: Recurring software subscriptions for pharmacy management, hospital software, and medical practice solutions
  2. Hardware and Connected Devices: Sale of electronic devices and connected solutions for healthcare professionals and patients through e-Connect division
  3. Fintech/Financing Services: Equipment leasing and financing solutions for healthcare professionals (Fintech division)
  4. Systems and Equipment: Healthcare systems and equipment segment showing significant growth driven by healthcare investments and new product rollouts

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Equasens product offering

Product offering

Core offering

Equasens develops and sells software solutions and connected electronic devices for healthcare professionals across Europe. Its portfolio covers pharmacy management software, hospital and medico-social information systems, electronic patient records for physicians, connected medical devices, and equipment financing — organized across five divisions (Pharmagest, Axigate Link, Medical Solutions, e-Connect, Fintech) to support care coordination across the city-hospital-medico-social continuum.

Product overview

Equasens is a healthcare IT solutions provider organized into 5 strategic divisions: Pharmagest (pharmacy software), Axigate Link (hospital and medical-social software), Medical Solutions (physician practice management), e-Connect (connected medical devices), and Fintech (equipment financing). The company serves pharmacies, hospitals, care homes, physicians, and other healthcare professionals across Europe. The portfolio includes acquired brands like ADV (PHARMAGEST Germany), Erevo (digital training), and ResUrgences/DIS (hospital software), with a total customer base of 10,300 pharmacies, 3,400 care homes, 170 hospital-at-home units, 340 in-home nursing services, 11,300 doctors, and 40 hospitals.

Differentiator

Problem solved

Functional benefit

Products and services

  • Pharmagest European expert in technological solutions for pharmacies, providing software and connected solutions for pharmacy management, dispensing, inventory control, and patient management across Europe. Serves over 10,300 pharmacies.
  • Axigate Link European expert in software and applications for medico-social, health, and multidisciplinary establishments. Provides hospital information systems, patient records, inter-establishment coordination, and care pathway software for hospitals and medical-social institutions.
  • Medical Solutions Expert in Electronic Patient Records (EPR) and management of practices and nursing homes. Provides software for independent physicians (liberal doctors), group practices, MSPs (Maisons de Santé Pluriprofessionnelles), and CPTS (Communautés Professionnelles Territoriales de Santé).
  • e-Connect Designer and manufacturer of connected electronic devices and solutions for healthcare professionals and patients. Offers connected medical devices for pharmacy, hospital, and patient use as part of Equasens' integrated healthcare IT ecosystem.
  • Fintech Provides funding solutions for leased equipment for healthcare professions and other players in the services industry. Offers financing services (equipment leasing) to healthcare professionals to support acquisition of IT and medical equipment.
  • ADV (PHARMAGEST Germany) Germany-based pharmacy software company offering pharmacy software solutions for the German market. Acquired by Equasens in November 2023 to expand pharmacy software offerings and strengthen Equasens' presence in Germany.

Companies that use Equasens

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles5 records

Equasens technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Equasens partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered strategic, core and minor.

  • ErevostrategicStrategic or Co-development Partner · 5 January 2026Equasens acquired 80% controlling stake in French digital training company Erevo, expanding into continuing medical education market. Deal expected to generate approximately €7.4 million revenue for Erevo in 2025. Combines Erevo's training programs with Equasens' existing Atoopharm training unit for pharmacists.
  • ADV (PHARMAGEST Germany)coreStrategic or Co-development Partner · 1 November 2023Acquired Germany-based ADV (PHARMAGEST Germany) to expand pharmacy software offerings and strengthen presence in German market. Part of European expansion strategy.
  • AtoopharmcoreStrategic or Co-development PartnerTraining unit within Equasens providing continuing education for pharmacists. Combined with Erevo acquisition to create synergies in medical education market.
  • La Ligue contre le cancerminorGTM or Marketing PartnerCo-organized webinar on HPV vaccination in pharmacies with Equasens and Atoopharm to highlight public health issues and levers available to pharmacists for increasing vaccination rates.

Scale indicators12 records

Recent moves6 records

Expansion highlights5 records

Equasens competitors and assessment

Company assessment

Broad incumbents

  • Oracle Health (Cerner): Oracle Health (formerly Cerner) is a global EHR and healthcare IT incumbent serving large hospitals and health systems. It is an indirect competitor to Equasens at the high end of the European hospital market and pressures pricing on integrated care record initiatives.
  • Epic Systems: Epic Systems is a leading global EHR vendor increasingly penetrating European large hospital systems. While not a direct daily competitor to Equasens today, it sets the enterprise functionality benchmark that Equasens' Axigate Link hospital offering must differentiate against in public tenders.
  • Agfa HealthCare: Agfa HealthCare provides enterprise imaging, hospital IT, and digital radiology solutions to hospitals and health systems globally. It is a broader incumbent that competes with Equasens' Axigate Link hospital software offering, particularly in imaging-adjacent workflows.
  • Dedalus: Dedalus is one of Europe's largest healthcare IT vendors, focused on hospital and diagnostic information systems across multiple countries. It competes with Equasens' Axigate Link hospital and medico-social software at a broader, more enterprise-oriented scale.

Direct peers

  • Maincare Solutions: Maincare Solutions is a French hospital information system provider serving public hospitals and health territories. It is a direct peer to Equasens' Axigate Link division and competes for the same French public hospital and GHT (groupement hospitalier de territoire) contracts.
  • Cegedim: Cegedim is a French health technology group providing pharmacy management, physician EHR, and healthcare data solutions across Europe. It directly competes with Equasens' Pharmagest and Medical Solutions divisions and serves a similar B2B healthcare professional customer base.
  • CompuGroup Medical: CompuGroup Medical is a leading European health IT vendor with strong pharmacy software, physician practice, and hospital information system offerings, particularly in Germany. It is the most direct comparable to Equasens' pharmacy franchise and ADV (PHARMAGEST Germany) operations.
  • MIMS Group (Vidal): MIMS Group (formerly Vidal) provides drug information databases and clinical decision support to pharmacies and physicians across Europe and Asia. It overlaps with Equasens' pharmacy and physician software offerings where drug database integration and medication safety features are core functions.

Emerging players

  • Doctolib: Doctolib is the dominant European digital health platform for appointment booking, teleconsultation, and physician practice software in France and Germany. It overlaps with Equasens' Medical Solutions physician EHR offerings as an emerging cloud-native competitor.

Others

  • InterSystems: InterSystems provides health data platforms (HealthShare, IRIS for Health) used by hospital systems and national health authorities for interoperability. It is an enabling technology peer to Equasens' Healthcare Data Sharing Platform, competing as infrastructure rather than as a direct end-user application vendor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Equasens social profiles

Digital presence

Equasens financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Equasens leadership team

Management profile

Number of profiles

Equasens subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Equasens funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Equasens M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Equasens

What does Equasens do?

Equasens develops and sells software solutions and connected electronic devices for healthcare professionals across Europe. Its portfolio covers pharmacy management software, hospital and medico-social information systems, electronic patient records for physicians, connected medical devices, and equipment financing — organized across five divisions (Pharmagest, Axigate Link, Medical Solutions, e-Connect, Fintech) to support care coordination across the city-hospital-medico-social continuum.

Is Equasens a public or private company?

Equasens is a public company. It is classified as public and is currently operating.

When was Equasens founded?

Equasens was founded in 1996. It employs 251 to 500 people.

Where is Equasens based?

Equasens is headquartered in Villers-lès-nancy, France, in the Europe region.

How does Equasens make money?

Four revenue lines are on record. Software Subscriptions and Licenses are the primary driver. The others are hardware and Connected Devices, fintech/Financing Services and systems and Equipment.

Who are Equasens's main competitors?

Broad incumbents on record are Oracle Health (Cerner), Epic Systems, Agfa HealthCare and Dedalus. Direct peers are Maincare Solutions, Cegedim, CompuGroup Medical and MIMS Group (Vidal). Doctolib is listed as an emerging player. InterSystems is listed as an others.

Does Equasens have an API?

No public API is recorded for Equasens.

What industry is Equasens in?

Equasens's product category is Healthcare IT Software. Its primary akta.pro industry code is HLACAKAO, Pharmacy Interoperability, Standards & Integration (FHIR/NCPDP). Its NAICS code is 62 and its SIC code is 8000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireSolide performance commerciale au S1 2026 : Chiffre d’affaires semestriel de 124,5 M€ (+7,3% en publié) et ARR de 111,1 M€ au 30 juin 2026 (+8,8% vs. 30 juin 2025)Equasens, a digital health solutions provider listed on Euronext Paris, reported H1 2026 revenue of €124.5 million, representing 7.3% growth year-over-year (7.3% reported, 1.4% organic), driven by strong performance in maintenance and subscription services (€55.7M, +8.4%) and software and services (€21.7M, +24.9%). Annual Recurring Revenue reached €111.1 million as of June 30, 2026, up 8.8% year-over-year, with balanced contributions from organic growth and external acquisitions. The company remains focused on AI integration in its software offerings and SaaS development, while pursuing European expansion particularly in Italy.GlobeNewswireStrong H1 2026 business performance: H1 revenue of €124.5 million (+7.3% on a reported basis) and ARR of €111.1 million at 30 June 2026 (+8.8% vs. 30 June 2025)Equasens reported H1 2026 revenue of €124.5 million, up 7.3% on a reported basis and 1.4% like-for-like, driven by strong growth in maintenance and subscriptions (+8.4% to €55.7 million) and software and services (+24.9% to €21.7 million). Annual recurring revenue reached €111.1 million at 30 June 2026, up 8.8% year-over-year, with growth evenly split between organic expansion and acquisitions including EREVO, NOVAPROVE, and the DIS business. The PHARMAGEST Division generated entirely organic growth of 3.6%, while Italy posted 42.4% growth in its pharmacy and para-pharmacy segment, though Germany and Belgium both recorded revenue declines.GlobeNewswireSolide performance commerciale au S1 2026 : Chiffre d’affaires semestriel de 124,5 M€ (+7,3% en publié) et ARR de 111,1 M€ au 30 juin 2026 (+8,8% vs. 30 juin 2025)Equasens reported H1 2026 revenue of €124.5 million, up 7.3% on a reported basis, and ARR of €111.1 million at June 30, 2026, up 8.8% year-over-year. Maintenance and subscriptions grew 8.4% to €55.7 million, while the PHARMAGEST division saw solid organic growth in France and Italy.GlobeNewswireBILAN SEMESTRIEL S1 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC NATIXIS ODDO BHFEQUASENS, a French digital health solutions provider, has reported the semi-annual status of its liquidity contract with NATIXIS ODDO BHF as of June 30, 2026, following the transition from previous provider Gilbert Dupont on April 1, 2026. The liquidity account held 4,607 shares and €314,173 in cash, compared to 2,153 shares and €413,664 at initial setup, with H1 2026 trading activity totaling 68,917 purchased shares (€2.65M) and 66,811 sold shares (€2.56M). This routine market-making disclosure is standard practice for companies listed on Euronext Paris under French financial regulations.GlobeNewswireRESULTAT DU VOTE DES RESOLUTIONS PRESENTEES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLEEquasens held its Annual Ordinary General Meeting on June 25, 2026, at its headquarters in Villers-lès-Nancy, France, with an 87.8% quorum achieved among the 14.8 million shares eligible to vote. All 25 resolutions proposed by the Board of Directors were approved, including the approval of the 2025 annual and consolidated accounts, dividend distribution, board appointments and renewals, and executive compensation policies for 2026. The meeting also covered auditor appointments, board remuneration for 2026, and authorization for share buybacks.GlobeNewswireRESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THEEquasens Group held its Ordinary Annual Shareholders' Meeting on June 25, 2026, where all 25 proposed resolutions were adopted, including approval of the 2025 parent company and consolidated financial statements, setting of dividends, and various director appointments and renewals. The meeting achieved an 87.8% quorum with over 13 million shares with voting rights represented. The company also published its financial calendar for H2 2026, with H1 2026 revenue set to be released on July 30, 2026.GlobeNewswireEquasens renews its governance with the appointment of Dominique Pautrat as Chairman of the Board and four new directorsEquasens appointed Dominique Pautrat as Chairman of the Board, succeeding Thierry Chapusot, and added four new directors. The appointments follow the Board's meeting and aim to strengthen governance for the group's growth ambitions.GlobeNewswireANNUAL ORDINARY GENERAL MEETING: MEETING NOTICE - ONLINE AVAILABILITY OF MEETING MATERIALS - WEBCAST LIVEEQUASENS, a digital healthcare solutions provider listed on Euronext Paris, has published notice of its Annual Ordinary General Meeting scheduled for June 25, 2026 at its registered office in Villers-lès-Nancy, France. The meeting documents have been made available on the company's website since June 4, 2026, and the proceedings will be broadcast live online. The company, which employs over 1,500 people across Europe, specializes in providing digital applications and solutions for healthcare professionals.GlobeNewswireASSEMBLEE GENERALE ORDINAIRE ANNUELLE : AVIS DE CONVOCATION - MISE EN LIGNE DES DOCUMENTS PREPARATOIRES - RETRANSMISSION EN DIRECTEQUASENS, a French digital health solutions provider, has issued a notice convoking its Annual Ordinary General Meeting for June 25, 2026, at its headquarters in Villers-lès-Nancy, France. The meeting documents, voting forms, and procedures have been published on the company's official website since June 4, 2026, with the official notices published in the Mandatory Legal Announcements Bulletin. The company will webcast the entire meeting live, with connection details to be posted at least 48 hours prior to the event.openPR.comEmerging Sub-Segments Transforming the Pharmacy Automation Solution Market LandscapeThe pharmacy automation solution market is projected to reach $15.44 billion by 2030, growing at a 13% CAGR, driven by increased focus on patient safety, hospital infrastructure expansion, and AI-powered pharmacy systems. In November 2023, France-based EQUASENS acquired Germany-based ADV (PHARMAGEST Germany) to expand its pharmacy software offerings and strengthen its presence in the German market. In October 2024, US-based Alto Technologies Inc. launched a Pharmacy Technology Platform to streamline pharmacy processes using automation and AI.